The mice were imaged under anesthesia on a Carestream In-Vivo FX PRO (Carestream Health, Woodbridge, USA) using 550 nm excitation and 600 nm emission wavelength lters before application and 1, 2, 24 and 48 hours after application. They were then euthanized, and treated skins were xed in 4% paraformaldehyde (PFA) overnight at 4 o C for uorescent imaging.
In vivo fx pro
The In-Vivo FX PRO is a versatile imaging system designed for preclinical research. It provides high-resolution, non-invasive imaging of small animals. The system is capable of capturing multimodal images, including fluorescence, bioluminescence, and X-ray, to support a wide range of applications in life science research.
Lab products found in correlation
12 protocols using in vivo fx pro
Topical Application of Rho-SPIONs and Doxorubicin
The mice were imaged under anesthesia on a Carestream In-Vivo FX PRO (Carestream Health, Woodbridge, USA) using 550 nm excitation and 600 nm emission wavelength lters before application and 1, 2, 24 and 48 hours after application. They were then euthanized, and treated skins were xed in 4% paraformaldehyde (PFA) overnight at 4 o C for uorescent imaging.
Topical Application of Rho-SPIONs and Doxorubicin
The mice were imaged under anesthesia on a Carestream In-Vivo FX PRO (Carestream Health, Woodbridge, USA) using 550 nm excitation and 600 nm emission wavelength lters before application and 1, 2, 24 and 48 hours after application. They were then euthanized, and treated skins were xed in 4% paraformaldehyde (PFA) overnight at 4 o C for uorescent imaging.
Topical Nanoparticle-Mediated Delivery
The mice were imaged under anesthesia on a Carestream In Vivo FX PRO (Carestream Health, Woodbridge, USA) using 550 nm excitation and 600 nm emission wavelength filters before application and 1, 2, 24 and 48 h after application. They were then euthanized, and treated skins were fixed in 4% paraformaldehyde (PFA) overnight at 4 °C for fluorescent imaging.
Tissue Distribution of DiR-Labeled DPT-PM
Biodistribution of DiR-Labeled GlcA-NPplex in MCT-PH Rats
For the biodistribution study, the MCT-PH rats (3 rats/group) were intravenously injected with DiR-labeled GlcA-NPplex via the tail vein at a DiR dose of 0.5 mg/kg, according to the rats' body weight. The co-localization of the GlcA-NPplex with PA α-SMA (α-smooth muscle actin) in the models was studied using Leica Corp. IX 7 fluorescence microscopy (Leica Microsystems Inc. IX7, Wetzlar, Germany). The rats received intravenous administration of the free IR783-labeled preparations at 0.5 mg/kg IR783. Four hours after the treatment, the rats’ lungs were isolated and embedded with OCT for further fluorescent imaging. Briefly, the lung sections were cut into 2 μm and then blocked for 15 min with 5% FBS at room temperature. After the excess-serum removal, the sections were stained for 12 h with a mouse anti-rat α-SMA monoclonal antibody at 5 μg/mL and incubated with FITC (diluted 1:200 with FITC buffer) for 1 h.
In Vivo Bioluminescence Imaging
Biodistribution of Tumor-Targeted DiR Agents
In Vivo Fluorescence Imaging of Grafted Cells
In Vivo Bioluminescence Imaging
Bioluminescent Tumor Imaging in Mice
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!